GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shenzhen Weiguang Biological Products Co Ltd (SZSE:002880) » Definitions » Asset Impairment Charge

Shenzhen Weiguang Biological Products Co (SZSE:002880) Asset Impairment Charge : ¥0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Shenzhen Weiguang Biological Products Co Asset Impairment Charge?

Shenzhen Weiguang Biological Products Co's Asset Impairment Charge for the three months ended in Mar. 2024 was ¥0 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0 Mil.

Shenzhen Weiguang Biological Products Co Asset Impairment Charge Historical Data

The historical data trend for Shenzhen Weiguang Biological Products Co's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shenzhen Weiguang Biological Products Co Asset Impairment Charge Chart

Shenzhen Weiguang Biological Products Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Asset Impairment Charge
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Shenzhen Weiguang Biological Products Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Asset Impairment Charge Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Shenzhen Weiguang Biological Products Co Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

Shenzhen Weiguang Biological Products Co Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Shenzhen Weiguang Biological Products Co's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

Shenzhen Weiguang Biological Products Co (SZSE:002880) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shenzhen Weiguang Biological Products Co Ltd (SZSE:002880) » Definitions » Asset Impairment Charge
Comparable Companies
SZSE:300702 SZSE:000597 SHSE:688091 SZSE:300119 SZSE:301263 SHSE:688621 SZSE:000915 SZSE:000813 SZSE:002349 SZSE:000078 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
Guangming Street, No. 3402, Guangqiao Avenue, Guangming New District, Guangdong Province, Guangming, CHN, 518107
Website
http://www.szwg.com
Shenzhen Weiguang Biological Products Co Ltd is the pharmaceutical company. It is mainly engaged in the research and development, production and sales of blood products. The company's products portfolio includes human albumin, intravenous immunoglobulin (pH4), lyophilized human immunoglobulin (pH4), human immunoglobulin, hepatitis B human immunoglobulin, rabies immunoglobulin, tetanus Human immunoglobulin, histamine human immunoglobulin, human fibrinogen, a total of 21 varieties of 21 specifications.

Shenzhen Weiguang Biological Products Co (SZSE:002880) Headlines

No Headlines